Abstract Purpose: To explore the effects of Prunella vulgaris L extract (PVE) on hyperplasia of mammary gland (HMG) 
INTRODUCTION
Hyperplasia of mammary gland (HMG) is a common disease in middle-aged women. It is a kind of pathological hyperplasia of lobules of mammary gland induced by balance disorder of estrogen and progesterone. The morbidity of HMG is increasing nowadays, with a risk of causing mammary carcinoma. Therefore, it is important to search for more convenient and effective new drugs with few side effects for treating hyperplasia of mammary glands as well as explore the anti-HMG mechanisms of these drugs that would block its development into breast cancer [1] .
HMG is related to menstrual cycle, breastfeeding, occupation, abuse of sex hormone drugs, diet and stress [2, 3] . HMG patients have increased in number in recent years. Studies have shown that some Traditional Chinese Medicine products may improve regulatory mechanisms of the body that could inhibit HMG [4] .
Prunella vulgaris L, is a herb from barley that is widely used in China. It is capable of regulating endocrine disorder and is frequently used in the treatment of HMG [5] . The aim of the present study was to examine the therapeutic effect of Prunella vulgaris L extract against hyperplasia of mammary gland in rats.
EXPERIMENTAL Material
The [6] .
Animal groups
Rats were treated with estrogen (0.5 mg/kg) intra-muscularly for 25 days, followed by progestogen (5 mg/kg) for another 5 days to induce HMG model. The rats were randomly divided into 6 groups of ten rats: normal group, model group, positive group (Rupixiao Capsule, RPXC 400 mg/kg) as well as PVE groups (150, 300 and 600 mg/kg doses). From the 31st day, the rats in the normal group and model group received distilled water by gavage, the rats in RPXC group were treated with RPXC, and the rats in the PVE group were respectively administered PVE by intragastric administration. Treatments were given orally once daily for 4 weeks.
Cotton pellet-induced granuloma
Sterile cotton pellets (10 mg) were implanted subcutaneously in groin of anesthetized mice (18 -22 g). Ten animals were used for every treatment. The animals received 150, 300 and 600 mg/kg of PVE, RPXC (400 mg/kg) or saline (10 ml/kg) orally, once a day through an oral cannula over 7 consecutive days. On the 8th day, the mice were sacrificed and the cotton pellet removed, dried overnight at 60 °C and weighed. The increase in weight of cotton pellet was determined and used for further calculation.
Determination of nipple height and biochemical assay
The nipple height of all rats were measured after the treatment. The contents of sex hormones -E2, P, PRL, FSH and LH -were determined using ELISA kits (Nanjing Jiancheng Co Ltd, China). Uterus index was calculated as uterus weight divided by body weight, while ovary index derived as the ratio of ovary weight to body weight.
Statistical analysis
Values are expressed as mean ± SEM. Multiple group comparisons were performed using oneway analysis of variance (ANOVA) followed by Dunnett's test to detect intergroup differences. P < 0.05 was considered statistically significant in all cases.
RESULTS

Cotton pellet-induced granuloma
The results revealed that PVE significantly inhibited the dried weight of the cotton pellet granuloma in a dose-dependent manner. The values for doses of 150, 300 and 600 mg/kg PVE were 18.15, 22.24 and 28.14 %, respectively. RPXC inhibited granuloma tissue formation by 17.21 %, which is lower than that observed for 100 mg/kg dose of PVE. Thus, PVE significantly suppressed granulomatous tissue formation during chronic inflammation ( Table 1) .
Effect of PVE on rat nipple height
The height of nipples (right 2 and right 3) of rats was significantly decreased by RPXC (400 mg/kg) and PVE (600 mg/kg) treatments compared with HMG control group (p < 0.01, Table 2 ). 
Effect of PVE on rat serum sex hormone levels
After injection of estrogen and progestogen, E2, PRL and FSH contents were significantly increased, while P and LH levels decreased in HMG control rats. E2, PRL and FSH were decreased by PVE (600 mg/kg) treatment compared with model group (p < 0.01), P and LH contents was remarkably increased compared to HMG control group (p < 0.01) ( Table 3) .
Effect of PVE on uterus and ovary index in rats
Uterus index in HMG model rats were significantly increased compared with normal group (p < 0.01). Uterus index was significantly decreased by RPXC (400 mg/kg) (p < 0.01) and PVE (600 mg/kg) (p < 0.05) treatment as compared with HMG model group. Ovary index was not shown distinct difference compared with control group (Table 4) .
DISCUSSION
There is evidence that chronic inflammation brought about by persistent chemical, bacterial or viral agents is a risk factor for cancer [7] [8] [9] [10] . Inflammation by innate immunity, which is required to fight microbial infections, heal wounds and maintain tissue homeostasis, can lead to cancer [11] [12] [13] . Several recent studies have suggested that inflammation has an important role in all phases of tumor development, including tumor initiation, tumor promotion, invasion, metastatic dissemination, and evasion of immune system [14] . The development of many types of cancer including breast cancer is related to inflammation.
Epidemiological studies have revealed that the use of non-steroidal anti-inflammatory drugs can decrease the risk of developing breast cancer [15, 16] . The study revealed that PVE-H had strong anti-inflammatory activities in chronic inflammation model mice. The inflammatory granuloma is a typical feature of a chronic inflammatory process. The dried weight of the pellets correlates with the amount of granulomatous tissue. Therefore, cotton pellet granuloma method has been widely used to evaluate the proliferative components of chronic inflammation.
In the present study, PVE inhibited chronic proliferative inflammation processes with a dosedependent inhibition of granuloma formation in mice, and also has ameliorative effects in HMG rats induced by estrogen and progestogen. The heights of nipples of rats were significantly decreased by PVE-H treatment compared with control. Results showed that uterus index were remarkably decreased by PVE-H treatment compared with HMG model group. Ovary index was not shown distinct difference compared with control group. After administration of PVE-H in HMG rats, E2, PRL and FSH were remarkably decreased, while P and LH significantly increased in relation to control.
CONCLUSION
The findings of this study demonstrate that PVE significantly inhibits mammary gland hyperplasia in rats. Therefore, the plant has the potential to be developed as a treatment of HMG in patients.
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